MX9703244A - Expresion de lactoferrina recombinante procesada yfragmentos del polipeptido lactoferrina a partir de un producto de fusion en aspergillus. - Google Patents

Expresion de lactoferrina recombinante procesada yfragmentos del polipeptido lactoferrina a partir de un producto de fusion en aspergillus.

Info

Publication number
MX9703244A
MX9703244A MX9703244A MX9703244A MX9703244A MX 9703244 A MX9703244 A MX 9703244A MX 9703244 A MX9703244 A MX 9703244A MX 9703244 A MX9703244 A MX 9703244A MX 9703244 A MX9703244 A MX 9703244A
Authority
MX
Mexico
Prior art keywords
aspergillus
lactoferrin
ragments
expression
fusion product
Prior art date
Application number
MX9703244A
Other languages
English (en)
Inventor
Orla M Conneely
Denis R Headon
Bert W O'malley
Original Assignee
Agennix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agennix Inc filed Critical Agennix Inc
Publication of MX9703244A publication Critical patent/MX9703244A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion proporciona la produccion de lactoferrinas y fragmentos del polipéptido lactoferrina, usando las células huésped Aspergillus en combinacion con construcciones plasmídicas nuevas. Más especificamente, la presente invencion proporciona construcciones de vectores novedosos capaces de producir lactoferrinas y fragmentos del polipéptido lactoferrina en células huésped Aspergillus. Más particularmente, la presente invencion proporciona construcciones plasmidicas nuevas apropiadas para usarse con las células huésped de Aspergillus y especialmente con Aspergillus awamori, niger y oryzae, las cuales son capaces de producir luego grandes cantidades de lactoferrinas recombinantes y fragmentos del polipéptido de lactoferrina.
MX9703244A 1994-11-02 1997-05-02 Expresion de lactoferrina recombinante procesada yfragmentos del polipeptido lactoferrina a partir de un producto de fusion en aspergillus. MX9703244A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/303,009 US5571697A (en) 1989-05-05 1994-11-02 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus

Publications (1)

Publication Number Publication Date
MX9703244A true MX9703244A (es) 1998-07-31

Family

ID=23170177

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703244A MX9703244A (es) 1994-11-02 1997-05-02 Expresion de lactoferrina recombinante procesada yfragmentos del polipeptido lactoferrina a partir de un producto de fusion en aspergillus.

Country Status (11)

Country Link
US (3) US5571697A (es)
EP (1) EP0871724A1 (es)
JP (1) JPH10509317A (es)
KR (1) KR100443307B1 (es)
CN (1) CN1230537C (es)
AU (1) AU4279896A (es)
CA (1) CA2204246A1 (es)
DE (1) DE871724T1 (es)
ES (1) ES2127164T1 (es)
MX (1) MX9703244A (es)
WO (1) WO1996014413A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
IL94183A (en) * 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof
US7883872B2 (en) * 1996-10-10 2011-02-08 Dyadic International (Usa), Inc. Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
US5811381A (en) * 1996-10-10 1998-09-22 Mark A. Emalfarb Cellulase compositions and methods of use
DE69943375D1 (de) * 1998-08-19 2011-06-01 Monsanto Technology Llc Pflanzliche expressionsvektoren
US6592814B2 (en) * 1998-10-02 2003-07-15 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
DE69922978T2 (de) * 1998-10-06 2005-12-08 Emalfarb, Mark Aaron, Jupiter Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen
US6399570B1 (en) 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US7138150B2 (en) * 2000-05-02 2006-11-21 Ventria Bioscience Method of making an anti-infective composition for treating oral infections
US7417178B2 (en) * 2000-05-02 2008-08-26 Ventria Bioscience Expression of human milk proteins in transgenic plants
US20080050503A1 (en) * 2000-05-02 2008-02-28 Ning Huang Expression of human milk proteins in transgenic plants
WO2003057712A2 (en) * 2001-12-28 2003-07-17 Campina B.V. Humanized lactoferrin and uses thereof
CN101044154A (zh) * 2002-02-14 2007-09-26 威廉·J·鲁特 治疗宿主中切割的嵌合分子
CN1659187A (zh) * 2002-05-10 2005-08-24 新世纪药品有限公司 融合铁蛋白在疫苗和其他方面的应用
PT1507554E (pt) 2002-05-10 2011-11-21 Agennix Inc Lactoferrina no tratamento de neoplasmas malignos e outras doenças hiperproliferativas
US7238661B2 (en) * 2002-05-24 2007-07-03 Agennix, Inc. Oral lactoferrin in the treatment of respiratory disorders
ES2224792B1 (es) * 2002-06-28 2007-02-16 Era Plantech, S.L. Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas.
CA2499014A1 (en) 2002-09-16 2004-03-25 Agennix Incorporated Lactoferrin compositions and methods of wound treatment
WO2004052281A2 (en) * 2002-12-06 2004-06-24 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
WO2004052305A2 (en) 2002-12-10 2004-06-24 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
WO2004103285A2 (en) * 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrin in the treatment of diabetes mellitus
EP1635766A4 (en) * 2003-06-06 2009-09-30 Agennix Inc LACTOFERRIN AS ADJUVANS IN CANCER VACCINES
US20040259770A1 (en) * 2003-06-19 2004-12-23 Rush University Medical Center Method for determining leukocyte activation
WO2005018542A2 (en) * 2003-07-10 2005-03-03 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
AU2004270815B2 (en) 2003-09-11 2011-06-02 Novozymes Adenium Biotech A/S Recombinant production of antimicrobial agents
WO2005035569A2 (en) * 2003-10-10 2005-04-21 Five Prime Therapeutics, Inc. Kiaa0779, splice variants thereof, and methods of their use
AU2004297259A1 (en) * 2003-12-09 2005-06-23 Ventria Bioscience High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
JP4634809B2 (ja) * 2005-01-05 2011-02-16 株式会社アップウェル アポタンパク質の製造方法
US20060211089A1 (en) * 2005-03-16 2006-09-21 Novozymes A/S Expression of defensins in filamentous fungi
CN101505781A (zh) 2006-06-22 2009-08-12 阿根尼克斯有限公司 作为辐射防护物质的乳铁蛋白
US8680252B2 (en) 2006-12-10 2014-03-25 Dyadic International (Usa), Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
US9862956B2 (en) 2006-12-10 2018-01-09 Danisco Us Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
NZ555163A (en) 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
CA2695830A1 (en) 2007-08-08 2009-02-12 Novozymes Biopharma Dk A/S Transferrin variants and conjugates
WO2009033071A2 (en) * 2007-09-07 2009-03-12 Dyadic International, Inc. Novel fungal enzymes
DK2391225T3 (da) * 2009-01-28 2020-07-20 Perraudin Jean Paul Fremgangsmåde til fremstilling af lactoferrin
JP2012516878A (ja) 2009-02-06 2012-07-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 精製プロセス
EP3243835B1 (en) 2009-02-11 2024-04-10 Albumedix Ltd Albumin variants and conjugates
CN102414323B (zh) * 2009-04-22 2015-07-08 帝斯曼知识产权资产管理有限公司 用于生产感兴趣的重组多肽的方法
JP2013520475A (ja) 2010-02-25 2013-06-06 アゲンニックス・アーゲー 重症敗血症の治療における経口ラクトフェリン
KR102139454B1 (ko) 2012-07-03 2020-08-03 가오 가부시키가이샤 유용미생물 및 목적물질의 제조방법
CN103421794B (zh) * 2013-08-08 2014-07-02 华南理工大学 一种黑曲霉组成型表达元件、表达载体、重组黑曲霉及其构建方法和应用
CN108893415B (zh) * 2018-07-31 2022-12-27 上海凯圣生物科技有限公司 曲霉菌株及利用曲霉菌株发酵生产人乳铁蛋白的方法
WO2024056643A1 (en) * 2022-09-15 2024-03-21 Novozymes A/S Fungal signal peptides

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4710465A (en) * 1984-04-19 1987-12-01 Yale University Junction-fragment DNA probes and probe clusters
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4965190A (en) * 1986-07-31 1990-10-23 Howard Hughes Medical Institute Methods for the identification of mutations in the human phenylalanine hydroxylase gene using DNA probes
US5019508A (en) * 1987-08-27 1991-05-28 Biotechnology Research Partners, Ltd. Synovial phospholipases
US5081227A (en) * 1988-03-04 1992-01-14 La Jolla Cancer Research Foundation Germ cell alkaline phosphatase
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
US5571691A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
IL94183A (en) * 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
EP0429628B1 (en) * 1989-06-16 1998-09-02 Genencor International, Inc. Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
UA27702C2 (uk) * 1989-09-27 2000-10-16 Гіст-Брокейдс Н.В. Фрагмент геномної днк, що кодує фітазу aspergillus niger,фрагмент кднк, що кодує фітазу aspergillus niger, рекомбінантна плазмідна днк для експресії фітази в aspergillus (варіанти), штам aspergillus-продуцент фітази aspergillus (варіанти), спосіб одержання фітази, рекомбінанта фітаза aspergillus niger
IL95697A0 (en) * 1989-09-28 1991-06-30 Granada Biosciences Inc Cdna sequence for porcine lactoferrin protein
AU7453391A (en) * 1990-03-08 1991-10-10 Ferrodynamics, Inc. Genetically engineered human lactoferrin
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JPH07502723A (ja) * 1991-02-08 1995-03-23 ザ・ユニバーシテイ・オブ・バーモント・アンド・ステイト・アグリカルチユラル・カレツジ 組み替えトランスフェリン、トランスフェリン半−分子、及びそれらの突然変異体
EP0672149B1 (en) * 1991-12-09 2001-08-08 Unilever Plc PROCESS FOR PRODUCING/SECRETING A PROTEIN BY A TRANSFORMED MOULD USING EXPRESSION/SECRETION REGULATING REGIONS DERIVED FROM AN $i(ASPERGILLUS) ENDOXYLANASE II GENE
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin

Also Published As

Publication number Publication date
CA2204246A1 (en) 1996-05-17
US5955316A (en) 1999-09-21
AU4279896A (en) 1996-05-31
EP0871724A4 (es) 1998-10-21
CN1230537C (zh) 2005-12-07
CN1171815A (zh) 1998-01-28
KR970707283A (ko) 1997-12-01
ES2127164T1 (es) 1999-04-16
KR100443307B1 (ko) 2004-11-08
JPH10509317A (ja) 1998-09-14
US5571697A (en) 1996-11-05
DE871724T1 (de) 1999-06-02
US6080559A (en) 2000-06-27
WO1996014413A1 (en) 1996-05-17
EP0871724A1 (en) 1998-10-21

Similar Documents

Publication Publication Date Title
MX9703244A (es) Expresion de lactoferrina recombinante procesada yfragmentos del polipeptido lactoferrina a partir de un producto de fusion en aspergillus.
KR100221404B1 (en) Production of recombinant human lactoferrin
UA27702C2 (uk) Фрагмент геномної днк, що кодує фітазу aspergillus niger,фрагмент кднк, що кодує фітазу aspergillus niger, рекомбінантна плазмідна днк для експресії фітази в aspergillus (варіанти), штам aspergillus-продуцент фітази aspergillus (варіанти), спосіб одержання фітази, рекомбінанта фітаза aspergillus niger
AU5661890A (en) Human lactoferrin cdna sequence
EP1003379A4 (en) NEW PHYTASE
GR3024752T3 (en) Pea protein hydrolyzate, method for production thereof and use thereof
HU9502608D0 (en) Process for production of protein
NZ301858A (en) Expression of thrombopoietin
IL102783A0 (en) Dna sequence encoding bovine alpha-lactalbumin and methods of use
IL125771A0 (en) Recombinant ribonuclease proteins
AU3382097A (en) Aspergillus oryzae 5-aminolevulinic acid synthases and nucleic acids encoding same
MX9606610A (es) Produccion incrementada de beta-galactosidasa en aspergillus oryzae.
ZA957750B (en) Process for producing recombinant proteins plasmids and modified cells
ES2087092T3 (es) Procedimiento para la expresion de poligalacturonidasa y pectinesterasa en aspergillus niger y aspergillus awamori.
IL137256A0 (en) Frozen food product
UA27696C2 (uk) Saf-поліпептид, фрагмент днк, що кодує saf-поліпептид, рекомбінантна плазмідна днк для експресії safполіпептиду (варіанти), штам грибів streptomyces lividans, спосіб експресії saf-поліпептиду
EP1030867A4 (en) MAMMAL MILK GROWTH FACTOR
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU1879097A (en) Fragments of cr1 and their use
GB2318793A (en) Mpt83 gene from mycobacterium tuberculosis
TW370564B (en) The process for producing rice Cn/Zn-superoxide dismutase
TH13966A (th) การผลิตรีคอมบิแนนท์แลคโตเฟอร์รินของคน

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees